Work

826: Primary T-prolymphocytic leukemia (T-PLL) cells are sensitive to BCL-2 and HDAC inhibitors: Results from high-throughput ex vivo drug testing

Year: 2014

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(14)50729-0

Authors: E. Andersson, T. Pemovska, A. Lauhio, P. Pietarinen, C. Mateos, E. Faber, T. Brümmendorf, O. Kallioniemi, K. Wennerberg, S. Mustjoki

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2312185002

FWCI:

Cites:

Cited by: 1

Related to: 10